European Reference Networks are a key EU infrastructure to partner for research activities, the why and the how Virtual event
02.12.24 - 02.12.24
2 December 2024 | 17:00 - 17:45 | Virtual event
The European Reference Networks (ERNs), despite their significant potential for public-private partnerships, are often overlooked as key collaborators for research activities by pharmaceutical and biotech companies. This oversight stems primarily from a lack of knowledge and understanding of the ERNs' valuable assets (quality of the networks/data/infrastructure) and capabilities within the industry.
Many professionals in pharma and biotech are unaware of the extensive patient data, clinical expertise, and collaborative infrastructure that ERNs offer, missing opportunities for mutually beneficial public-private partnerships. These partnerships could leverage the strengths of both sectors: the public health focus and patient access of ERNs, combined with the research capabilities and resources of industry. To bridge this gap and catalyze such collaborations, an educational webinar targeting industry stakeholders is essential. This initiative aims to showcase the ERNs' unique strengths and demonstrate how public-private partnerships can accelerate rare disease research and drug development, ultimately benefiting patients and advancing medical science.
Main objectives:
- Provide a comprehensive overview of ERNs’ core mission within the European healthcare landscape.
- Detail the specific resources, expertise, and infrastructure ERNs offer, positioning them as valuable partners for conducting research activities in Europe.
- Illustrate how collaborations between ERNs and the private sector can accelerate rare disease research and drug development, benefiting both industry goals and public health outcomes, while done in a straightforward way.
- Acknowledge the diversity of ERNs’ maturity and expertise and capabilities in conducting research activities in partnership with the industry.
Register here.
